LivaNova PLC (NASDAQ:LIVN) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $81.92 and last traded at $81.08, with a volume of 258700 shares changing hands. The stock had previously closed at $80.26.

A number of equities research analysts have issued reports on LIVN shares. Needham & Company LLC raised shares of LivaNova PLC from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a research note on Thursday, September 14th. Piper Jaffray Companies reissued an “overweight” rating and set a $75.00 target price on shares of LivaNova PLC in a research note on Tuesday, September 12th. Jefferies Group LLC started coverage on shares of LivaNova PLC in a research note on Friday, September 8th. They set a “buy” rating and a $76.00 target price for the company. BidaskClub lowered shares of LivaNova PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Finally, ValuEngine raised shares of LivaNova PLC from a “hold” rating to a “buy” rating in a research note on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $77.86.

The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.42 and a current ratio of 2.03. The firm has a market cap of $3,869.46, a P/E ratio of 23.13, a PEG ratio of 2.41 and a beta of 0.52.

LivaNova PLC (NASDAQ:LIVN) last released its quarterly earnings data on Thursday, November 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.17. LivaNova PLC had a net margin of 4.63% and a return on equity of 9.33%. The business had revenue of $309.70 million during the quarter, compared to analyst estimates of $301.22 million. During the same quarter in the previous year, the business earned $0.78 EPS. LivaNova PLC’s quarterly revenue was up 4.9% compared to the same quarter last year. equities research analysts anticipate that LivaNova PLC will post 3.33 EPS for the current year.

In related news, Director Daniel Jeffrey Moore sold 1,000 shares of LivaNova PLC stock in a transaction on Monday, October 16th. The shares were sold at an average price of $74.58, for a total value of $74,580.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.28% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Jane Street Group LLC bought a new position in LivaNova PLC in the 3rd quarter worth $611,000. PEAK6 Investments L.P. raised its holdings in LivaNova PLC by 349.5% in the 3rd quarter. PEAK6 Investments L.P. now owns 30,414 shares of the company’s stock worth $2,131,000 after acquiring an additional 23,648 shares during the period. NWQ Investment Management Company LLC raised its holdings in LivaNova PLC by 71.2% in the 3rd quarter. NWQ Investment Management Company LLC now owns 500,594 shares of the company’s stock worth $35,072,000 after acquiring an additional 208,264 shares during the period. Invictus RG bought a new position in LivaNova PLC in the 3rd quarter worth $385,000. Finally, OxFORD Asset Management LLP raised its holdings in LivaNova PLC by 209.8% in the 3rd quarter. OxFORD Asset Management LLP now owns 23,136 shares of the company’s stock worth $1,607,000 after acquiring an additional 15,668 shares during the period. Hedge funds and other institutional investors own 82.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was first posted by Daily Political and is the property of of Daily Political. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.dailypolitical.com/2017/11/14/livanova-plc-livn-sets-new-52-week-high-at-81-92.html.

About LivaNova PLC

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.